Model selection: comparison of the total residual deviance and DIC for Bayesian network meta-analyses with fixed or random treatment effects and baseline BCVA and/or CRT as covariates.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
*Relative treatment effect for ranibizumab 0.5 mg PRN versus aflibercept 2.0 mg bi-monthly. BCVA, best-corrected visual acuity; CrI, credible interval; CRT, central retinal thickness; DIC, deviance information criterion; OR, odds ratio; PRN; pro re nata (as needed); VEGF, vascular endothelial growth factor.
创建时间：
2014-07-16
